BPBA
(Synonyms: 2-溴吡啶-5-硼酸,2-Bromopyridine-5-boronic acid) 目录号 : GC60659BPBA(2-Bromopyridine-5-boronicacid)是一种新的标记试剂,用于衍生化油菜素类固醇(BRs)。
Cas No.:223463-14-7
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
BPBA (2-Bromopyridine-5-boronic acid) is a new labeling reagent to derivatize brassinosteroids (BRs)[1].
[1]. Feifeng Huo, et al. A New Derivatization Approach for the Rapid and Sensitive Analysis of Brassinosteroids by Using Ultra High Performance Liquid Chromatography-Electrospray Ionization Triple Quadrupole Mass Spectrometry. Talanta. 2012 Sep 15;99:420-5.
Cas No. | 223463-14-7 | SDF | |
别名 | 2-溴吡啶-5-硼酸,2-Bromopyridine-5-boronic acid | ||
Canonical SMILES | OB(C1=CC=C(Br)N=C1)O | ||
分子式 | C5H5BBrNO2 | 分子量 | 201.81 |
溶解度 | DMSO : 100 mg/mL (495.52 mM; Need ultrasonic) | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 4.9552 mL | 24.7758 mL | 49.5516 mL |
5 mM | 0.991 mL | 4.9552 mL | 9.9103 mL |
10 mM | 0.4955 mL | 2.4776 mL | 4.9552 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Concurrent suppression of Aβ aggregation and NLRP3 inflammasome activation for treating Alzheimer's disease
Chem Sci 2022 Feb 21;13(10):2971-2980.PMID:35382471DOI:10.1039/d1sc06071f.
Alzheimer's disease (AD) is a neurodegenerative illness accompanied by severe memory loss, cognitive disorders and impaired behavioral ability. Amyloid β-peptide (Aβ) aggregation and nucleotide-binding oligomerization domain (NOD)-like receptor protein 3 (NLRP3) inflammasome play crucial roles in the pathogenesis of AD. Aβ plaques not only induce oxidative stress and impair neurons, but also activate the NLRP3 inflammasome, which releases inflammatory cytokine IL-1β to trigger neuroinflammation. A bifunctional molecule, 2-[2-(benzo[d]thiazol-2-yl)phenylamino]benzoic acid (BPBA), with both Aβ-targeting and inflammasome-inhibiting capabilities was designed and synthesized. BPBA inhibited self- and Cu2+- or Zn2+-induced Aβ aggregation, disaggregated the already formed Aβ aggregates, and reduced the neurotoxicity of Aβ aggregates; it also inhibited the activation of the NLRP3 inflammasome and reduced the release of IL-1β in vitro and vivo. Moreover, BPBA decreased the production of reactive oxygen species (ROS) and alleviated Aβ-induced paralysis in transgenic C. elegans with the human Aβ42 gene. BPBA exerts an anti-AD effect mainly through dissolving Aβ aggregates and inhibiting NLRP3 inflammasome activation synergistically.
A triphenylamine-functionalized luminescent sensor for efficient p-nitroaniline detection
Dalton Trans 2018 May 29;47(21):7222-7228.PMID:29756136DOI:10.1039/c8dt01240g.
The combination of π-conjugated fluorophores within a hybrid system gives rise to a triphenylamine-functionalized material [Zn(BPBA)(NO3)] (1) (Hbpba = 4-(bis(4-(pyridin-4-yl)phenyl)amino)benzoic acid). Compound 1 features a 2D + 2D → 2D parallel polycatenation structure with 63-hcb net. Photophysical studies revealed that the title phase showed superior sensitivity towards p-nitroaniline (p-NA) with a low detection limit (down to ∼0.10 ppm). Specifically, following a new detection route, vapor-sensing experiments using a saturated ethanol solution of nitroaromatic isomers have been established for the first time. Highly sensitive and selective detection of p-NA by the proposed material with a rapid response time (t = 30 s, QE > 90.0%) as compared to that via the control isomers (t = 60s, QE < 6.0%) demonstrates an attractive feasible route and a promising luminescent sensor for nitroaromatic detection.
Microbial biodegradation of aromatic alkanoic naphthenic acids is affected by the degree of alkyl side chain branching
ISME J 2011 Mar;5(3):486-96.PMID:20962873DOI:10.1038/ismej.2010.146.
Naphthenic acids (NAs) occur naturally in oil sands and enter the environment through natural and anthropogenic processes. NAs comprise toxic carboxylic acids that are difficult to degrade. Information on NA biodegradation mechanisms is limited, and there are no studies on alkyl branched aromatic alkanoic acid biodegradation, despite their contribution to NA toxicity and recalcitrance. Increased alkyl side chain branching has been proposed to explain NA recalcitrance. Using soil enrichments, we examined the biodegradation of four aromatic alkanoic acid isomers that differed in alkyl side chain branching: (4'-n-butylphenyl)-4-butanoic acid (n-BPBA, least branched); (4'-iso-butylphenyl)-4-butanoic acid (iso-BPBA); (4'-sec-butylphenyl)-4-butanoic acid (sec-BPBA) and (4'-tert-butylphenyl)-4-butanoic acid (tert-BPBA, most branched). n-BPBA was completely metabolized within 49 days. Mass spectral analysis confirmed that the more branched isomers iso-, sec- and tert-BPBA were transformed to their butylphenylethanoic acid (BPEA) counterparts at 14 days. The BPEA metabolites were generally less toxic than BPBAs as determined by Microtox assay. n-BPEA was further transformed to a diacid, showing that carboxylation of the alkyl side chain occurred. In each case, biodegradation of the carboxyl side chain proceeded through beta-oxidation, which depended on the degree of alkyl side chain branching, and a BPBA degradation pathway is proposed. Comparison of 16S rRNA gene sequences at days 0 and 49 showed an increase and high abundance at day 49 of Pseudomonas (sec-BPBA), Burkholderia (n-, iso-, tert-BPBA) and Sphingomonas (n-, sec-BPBA).
A Fast and Selective Approach for Profiling Vicinal Diols Using Liquid Chromatography-Post Column Derivatization-Double Precursor Ion Scanning Mass Spectrometry
Molecules 2022 Jan 3;27(1):283.PMID:35011515DOI:10.3390/molecules27010283.
Vicinal diols are important signaling metabolites of various inflammatory diseases, and some of them are potential biomarkers for some diseases. Utilizing the rapid reaction between diol and 6-bromo-3-pyridinylboronic acid (BPBA), a selective and sensitive approach was established to profile these vicinal diols using liquid chromatography-post column derivatization coupled with double precursor ion scan-mass spectrometry (LC-PCD-DPIS-MS). After derivatization, all BPBA-vicinal-diol esters gave a pair of characteristic isotope ions resulting from 79Br and 81Br. The unique isotope pattern generated two characteristic fragment ions of m/z 200 and 202. Compared to a traditional offline derivatization technique, the new LC-PCD-DPIS-MS method retained the capacity of LC separation. In addition, it is more sensitive and selective than a full scan MS method. As an application, an in vitro study of the metabolism of epoxy fatty acids by human soluble epoxide hydrolase was tested. These vicinal-diol metabolites of individual regioisomers from different types of polyunsaturated fatty acids were easily identified. The limit of detection (LOD) reached as low as 25 nM. The newly developed LC-PCD-DPIS-MS method shows significant advantages in improving the selectivity and therefore can be employed as a powerful tool for profiling vicinal-diol compounds from biological matrices.
Correlation between patella and patellar tendon width: An anatomic study
Clin Anat 2012 Apr;25(3):398-400.PMID:21853464DOI:10.1002/ca.21241.
Anterior cruciate ligament (ACL) rupture is a common injury among orthopaedic patients with many different treatment modalities including bone-patella-bone autograft (BPBA) ACL reconstruction. Patella tendon width has been reported to be a predictor of recovery speed and success following BPBA repair. This study reports on the strength of the relationship between patella width and patella tendon width. Twenty fresh frozen cadavers were included in the study. Patella and patellar tendon measurements were recorded at the midpoint of the patellar tendon. Pearson correlation and linear regression were used to determine the relationship between patella width and patellar tendon width. Bivariate correlations with 95% confidence intervals and coefficients of determination (R(2) ) are reported. The study used 20 cadavers, 12 men and 8 women with a mean age of 72 (standard deviation [SD] = 12; range = 44 to 87). The mean patella width was 49.24mm (SD = 4.11; range 42.33mm-56.33mm) while the mean patellar tendon width was 26.10mm (SD = 3.31; range 18.33mm-33.33mm). The correlation between patella width and patellar tendon width was 0.67 (95% confidence interval = 0.45 - 0.81). R(2), the percent of variance in patellar tendon width accounted for by patella width, was 0.45. The regression equation for predicting patellar tendon width (y) yielded a formula of y = 0.536 + -0.316 × patella width. A moderate correlation exists between patella width and patellar tendon width. Our data suggests that this correlation is strongest with wider patellas and is more loosely associated with smaller patellas.